Generic drug of the therapeutic class: Dermatology
active ingredients: Benzalkonium chloride
laboratory: Reckitt B UK-Depolabo
Cutaneous spray solution
100 ml spray bottle
Antisepsis of small wounds.
Dosage DETTOLPRO 0.2% Solution for cutaneous spray 100 ml spray bottle
For adults and children over 12 months: For use only for occasional, localized, short-term use. Apply on small, recent wounds to eliminate the usual bacteria associated with the infection of small wounds. The product should be sprayed to cover the entire wound and can be reapplied if the wound reopens.
For children aged 1 to 6 years: In case of doubt, seek advice from a pharmacist or health professional before use. Apply 1 spray to each wound (can only be applied to up to 4 wounds at a time) and leave for five minutes. If necessary, remove any excess liquid with a clean tissue or cotton ball.
For adults and children over 6 years of age: Apply a full dose (1 to 2 sprays) to each wound and allow to act for 5 minutes. If necessary, remove any excess liquid with a clean tissue or cotton ball.
This medicine is intended for a single daily use, for a maximum of 3 to 5 days. It should not be used continuously.
If you have any doubt about your symptoms or if your symptoms worsen, please contact a health professional.
Board. Surface covered by a complete spraying of the product.
Product delivered by area
Quantity of CBK *
(mg / cm²)
Board. Calculation of volume and weight by spray or ml
ml by spray
mg of product by spray
mg of CBK * by spraying
mg of CBK * per ml of product
* CBK: Benzalkonium Chloride
The product is not intended to improve wound healing or to be used to improve wound healing.
· Do not use in children 1 year old or younger.
· Persons with known hypersensitivity to benzalkonium chloride or to any of the excipients should not use DETTOLPRO 0.2%, a skin spray solution.
Dettolpro side effects
The post-marketing experience does not indicate specific adverse effects related to the topical application of DETTOLPRO 0.2%, cutaneous spray solution; side effects were limited to those usually reported with topical antiseptics. Other effects may occur. In general, the frequency of adverse effects with topical antiseptics is very rare (<1 / 10, 000).
Skin and subcutaneous tissue disorders:
Very rare (<1 / 10, 000) : cutaneous dystrophy, acrodermatitis, exacerbation of eczema, contact dermatitis, alopecia, rash.
General disorders and administration site defects:
Very rare (<1 / 10, 000): signs and symptoms of systemic allergic reactions, including papular rash, pruritus, rash. Local reactions including application site cracks, skin irritation, burning sensation, erythema, abnormal skin discolouration, or peeling.